MOH Valuation

Molina Healthcare Inc

Add to Watchlist

Advanced Chart

155.000

+2.69(1.766%)1D

Overview
Forecast
Valuation
Earnings

MOH Relative Valuation

MOH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MOH is overvalued; if below, it's undervalued.

Historical Valuation

Molina Healthcare Inc (MOH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.30 is considered Undervalued compared with the five-year average of 15.38. The fair price of Molina Healthcare Inc (MOH) is between 296.98 to 367.93 according to relative valuation methord. Compared to the current price of 155.00 USD , Molina Healthcare Inc is Undervalued By 47.81%.

Relative Value

Fair Zone

296.98-367.93

Current Price：155.00

47.81%

Undervalued

8.30

Trailing

Forward

4.68

EV/EBITDA

Molina Healthcare Inc. (MOH) has a current EV/EBITDA of 4.68. The 5-year average EV/EBITDA is 9.02. The thresholds are as follows: Strongly Undervalued below 6.29, Undervalued between 6.29 and 7.66, Fairly Valued between 10.38 and 7.66, Overvalued between 10.38 and 11.74, and Strongly Overvalued above 11.74. The current Forward EV/EBITDA of 4.68 falls within the Strongly Undervalued range.

5.22

EV/EBIT

Molina Healthcare Inc. (MOH) has a current EV/EBIT of 5.22. The 5-year average EV/EBIT is 9.88. The thresholds are as follows: Strongly Undervalued below 6.79, Undervalued between 6.79 and 8.33, Fairly Valued between 11.43 and 8.33, Overvalued between 11.43 and 12.98, and Strongly Overvalued above 12.98. The current Forward EV/EBIT of 5.22 falls within the Strongly Undervalued range.

0.18

Molina Healthcare Inc. (MOH) has a current PS of 0.18. The 5-year average PS is 0.51. The thresholds are as follows: Strongly Undervalued below 0.35, Undervalued between 0.35 and 0.43, Fairly Valued between 0.59 and 0.43, Overvalued between 0.59 and 0.67, and Strongly Overvalued above 0.67. The current Forward PS of 0.18 falls within the Strongly Undervalued range.

9.93

P/OCF

Molina Healthcare Inc. (MOH) has a current P/OCF of 9.93. The 5-year average P/OCF is 12.29. The thresholds are as follows: Strongly Undervalued below 5.05, Undervalued between 5.05 and 8.67, Fairly Valued between 15.92 and 8.67, Overvalued between 15.92 and 19.54, and Strongly Overvalued above 19.54. The current Forward P/OCF of 9.93 falls within the Historic Trend Line -Fairly Valued range.

12.32

P/FCF

Molina Healthcare Inc. (MOH) has a current P/FCF of 12.32. The 5-year average P/FCF is 12.83. The thresholds are as follows: Strongly Undervalued below 7.23, Undervalued between 7.23 and 10.03, Fairly Valued between 15.63 and 10.03, Overvalued between 15.63 and 18.43, and Strongly Overvalued above 18.43. The current Forward P/FCF of 12.32 falls within the Historic Trend Line -Fairly Valued range.

Molina Healthcare Inc (MOH) has a current Price-to-Book (P/B) ratio of 1.84. Compared to its 3-year average P/B ratio of 4.82 , the current P/B ratio is approximately -61.88% higher. Relative to its 5-year average P/B ratio of 5.43, the current P/B ratio is about -66.23% higher. Molina Healthcare Inc (MOH) has a Forward Free Cash Flow (FCF) yield of approximately 5.17%. Compared to its 3-year average FCF yield of 5.17%, the current FCF yield is approximately 0.14% lower. Relative to its 5-year average FCF yield of 7.85% , the current FCF yield is about -34.08% lower.

1.84

P/B

Median3y

4.82

Median5y

5.43

5.17

FCF Yield

Median3y

5.17

Median5y

7.85

Competitors Valuation Multiple

The average P/S ratio for MOH's competitors is 0.34, providing a benchmark for relative valuation. Molina Healthcare Inc Corp (MOH) exhibits a P/S ratio of 0.18, which is -47.34% above the industry average. Given its robust revenue growth of 15.66%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

MOH.N

Molina Healthcare Inc

Alignment Healthcare Inc

Performance Decomposition

Market capitalization of MOH decreased by 56.46% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 9.88B to 11.43B.

The secondary factor is the Margin Expansion, contributed -26.89%to the performance.

Overall, the performance of MOH in the past 1 year is driven by Revenue Growth. Which is more sustainable.

15.66%

9.88B → 11.43B

Revenue Growth

-26.89%

3.05 → 2.23

Margin Expansion

-45.23%

14.09 → 7.72

P/E Change

-56.46%